Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Clinical trial NCT06441097 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06441097
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2024-12-31
Primary completion: 2027-12-31
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.